期刊文献+

两种成人隐匿性自身免疫糖尿病亚型的谷氨酸脱羧酶抗体界值的探讨 被引量:3

Optimal cut-point of glutamic acid decarboxylase antibody (GAD-Ab) for differentiating two subtypes of latent autoimmune diabetes in adults (LADA)
下载PDF
导出
摘要 目的 探讨判别两种成人隐匿性自身免疫糖尿病(LADA)亚型的最佳谷氨酸脱羧酶抗体(GAD-Ab)界值及其诊断价值。 方法 绘制LADA患者GAD-Ab指数的频数分布图,进行曲线拟合。比较130例经典1型糖尿病、145例2型糖尿病和145例LADA患者的临床特点,利用受试者运筹特征(ROC)曲线比较不同GAD-Ab滴度对LADA患者中反映 LADA 1 型特征的胰岛素缺乏和反映LADA 2型特征的代谢综合征(MS)的诊断价值,确定诊断两种 LADA亚型的最佳 GAD-Ab界值。用放射配体法测定 GAD-Ab。 结果 (1) GAD-Ab 频数在 LADA患者中呈双峰分布模式。(2)以GAD Ab指数0.3为切点所区分的两组LADA患者具有差异的临床特征最多。(3)ROC曲线显示GAD Ab指数0.3是区分两种LADA亚型的最佳界值,其对胰岛素缺乏和MS诊断的敏感性和特异性分别为54 5%和92 1%,ROC曲线下面积为 0.79(与 0.5 相比,P<0.01)。 结论 GAD Ab指数0 3是区分LADA-1型和LADA-2型的最佳界值。 Objective To investigate the optimal cut-point of glutamate decarboxylase antibody (GAD-Ab) for differentiating two subtypes of latent autoimmune diabetes in adults (LADA). (Methods) The frequency distribution of GAD-Ab index in LADA was described, and the estimated curve was made. The clinical features were compared among 145 LADA, 145 type 2 and 130 type 1 diabetic patients. Receiver-operating characteristic (ROC) curve was used to evaluate the diagnostic value of GAD-Ab in insulin-deficiency (representing LADA-1 subtype) and metabolic syndrome (representing LADA-2 subtype), and the optimal cut- point of GAD-Ab was defined. GAD-Ab was (measured) with radioligand assay. Results (1) The frequency distribution of GAD-Ab index in (LADA) was bimodal. (2) The number of clinical features which had significant differences in the patients of two subgroups was increased when cut-point moved from index of 0.1 to 0.3; however, there was a contrary tendency when the cut-point moved from index of 0.4 to 0.7. (3) ROC curve demonstrated that the optimal cut-point for the diagnosis of two subtypes of LADA was at 0.3, with sensitivity and specificity of 54.5% and 92.1% respectively for insulin-deficiency and metabolic syndrome. The area under ROC curve was 0.79 (compared with 0.5, P<0.01). Conclusions The optimal cut-point for the (differentiation) of two subtypes of LADA was at the GAD-Ab index of 0.3.
出处 《中华糖尿病杂志(1006-6187)》 CSCD 北大核心 2005年第1期34-38,共5页
基金 湖南省卫生厅重点项目(2001 Z04) 湖南省科技厅项目(02SSY3065)
关键词 GAD-AB LADA 亚型 患者 诊断价值 成人隐匿性自身免疫糖尿病 谷氨酸脱羧酶抗体 ROC曲线 胰岛素缺乏 MS Latent autoimmune diabetes in adults Glutamate decarboxylase antibody ROC curve Diagnosis
  • 相关文献

参考文献3

二级参考文献22

  • 1王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 2[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80.
  • 3[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459.
  • 4[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189.
  • 5[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249.
  • 6[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626.
  • 7[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130.
  • 8[8]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev,2002,18:114-117.
  • 9Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42:359-362.
  • 10Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of β cell function in autoimmune diabetes. J Clin Endocrinol Metab, 2000,85:4619-4623.

共引文献124

同被引文献32

引证文献3

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部